Springer Nature Staff
From the Editors

Video: A decade of open access

What has made Nature Communications successful over the past ten years, and what to do the editors have in store for the next decade? 

Published in Chemistry

Go to the profile of Samantha Zimbler
Samantha Zimbler
Video: A decade of open access
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

Share with...

...or copy the link

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Nature Communications launched in 2010 as the first online-only, hybrid journal from Nature Research. Join our anniversary celebration with a video from past and present Chief Editors.

Featuring:

  • Elisa De Ranieri | Editor in Chief, Nature Communications
  • Magdalena Skipper | Editor in Chief, Nature (Former Editor in Chief, Nature Communications)
  • Enda Bergin | Chief Physical Sciences Editor, Nature Communications
  • David Gevaux | Editorial Director, Nature Research & BMC Physical Sciences Community Journals (Former Chief Physical Sciences Editor, Nature Communications)
  • Nathalie Le Bot | Chief Life Sciences Editor, Nature Communications
  • Niki Scaplehorn | Editorial Director, Nature Life Science Journals (Former Chief Life Sciences Editor, Nature Communications)
Go to the profile of Samantha Zimbler
Samantha Zimbler

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Sign In Register

Follow the Topic

Chemistry
Physical Sciences > Chemistry

Related Collections

With collections, you can get published faster and increase your visibility.

Health in Africa

We aim to promote high-quality research that advances our understanding of health issues in Africa, and advocates for better healthcare on the continent in line with the UN’s SDGs.

Publishing Model: Open Access

Deadline: Dec 31, 2025

Explore this collection

Computational methodology for drug discovery

This Collection aims to collate the latest advances in computational method development for drug discovery and medicinal chemistry, as well as their application in preclinical studies.

Publishing Model: Open Access

Deadline: Aug 31, 2025

Explore this collection

Recommended Content

Cookies

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website. You can decide for yourself which categories you want to deny or allow. Please note that based on your settings not all functionalities of the site are available.

Further information can be found in our privacy policy.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.